APO Research
Talk to an analyst

APO RESEARCH · REPORT

Biologics Regulatory Affairs Outsourcing

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Biologics Regulatory Affairs Outsourcing Market Analysis and Forecast 2026-2032

15 April 2026213 pages

Choose your research edition.

Industry ResearchBiologics Regulatory Affairs Outsourcing Industry Research Report 2026128 pages · $2,950 USDIndustry Growth & TrendsGlobal Biologics Regulatory Affairs Outsourcing Industry Growth and Trends Forecast to 2032110 pages · $3,450 USDMarket StructureGlobal Biologics Regulatory Affairs Outsourcing Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Biologics Regulatory Affairs Outsourcing Market Outlook and Growth Opportunities 2026$4,250 USDMarket Analysis & ForecastGlobal Biologics Regulatory Affairs Outsourcing Market Analysis and Forecast 2026-2032213 pages · $4,950 USD

Market perspective

The global Biologics Regulatory Affairs Outsourcing market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Biologics Regulatory Affairs Outsourcing is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Biologics Regulatory Affairs Outsourcing is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Biologics Regulatory Affairs Outsourcing is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Biologics Regulatory Affairs Outsourcing is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Biologics Regulatory Affairs Outsourcing include Lonza AG, Wuxi AppTec Inc., Thermo Fisher Scientific Inc., Eurofins Scientific SE, Freyr solutions, Catalent Inc., Piramal Group, AGC Biologics and ICON Plc., etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Biologics Regulatory Affairs Outsourcing, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Biologics Regulatory Affairs Outsourcing, also provides the revenue of main regions and countries. Of the upcoming market potential for Biologics Regulatory Affairs Outsourcing, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Biologics Regulatory Affairs Outsourcing revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Biologics Regulatory Affairs Outsourcing market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Biologics Regulatory Affairs Outsourcing revenue, projected growth trends, production technology, application and end-user industry.

Biologics Regulatory Affairs Outsourcing Segment by Company

Lonza AG

Wuxi AppTec Inc.

Thermo Fisher Scientific Inc.

Eurofins Scientific SE

Freyr solutions

Catalent Inc.

Piramal Group

AGC Biologics

ICON Plc.

Charles River Laboratories International, Inc.

Labcorp

Parexel International

Medpace Holdings, Inc.

IQVIA

Syneos Health

SGS SA (SGS)

Biologics Regulatory Affairs Outsourcing Segment by Type

Regulatory Consulting

Legal Representation

Regulatory Writing & Publishing

Product Registration

Regulatory Submissions

Regulatory Operations

Others

Biologics Regulatory Affairs Outsourcing Segment by Application

Monoclonal Antibodies (mAbs)

Recombinant Proteins

Vaccines

Cell & Gene Therapies

Biosimilars

Others

Biologics Regulatory Affairs Outsourcing Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Biologics Regulatory Affairs Outsourcing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Biologics Regulatory Affairs Outsourcing and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Biologics Regulatory Affairs Outsourcing.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Biologics Regulatory Affairs Outsourcing in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Biologics Regulatory Affairs Outsourcing company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Biologics Regulatory Affairs Outsourcing revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Biologics Regulatory Affairs Outsourcing Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Regulatory Consulting Major Player Table 3. Legal Representation Major Player Table 4. Regulatory Writing & Publishing Major Player Table 5. Product Registration Major Player Table 6. Regulatory Submissions Major Player Table 7. Regulatory Operations Major Player Table 8. Others Major Player Table 9. Global Biologics Regulatory Affairs Outsourcing Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 10. Monoclonal Antibodies (mAbs) Major Player Table 11. Recombinant Proteins Major Player Table 12. Vaccines Major Player Table 13. Cell & Gene Therapies Major Player Table 14. Biosimilars Major Player Table 15. Others Major Player Table 16. Biologics Regulatory Affairs Outsourcing Industry Trends Table 17. Biologics Regulatory Affairs Outsourcing Industry Drivers Table 18. Biologics Regulatory Affairs Outsourcing Industry Opportunities and Challenges Table 19. Biologics Regulatory Affairs Outsourcing Industry Restraints Table 20. Global Biologics Regulatory Affairs Outsourcing Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 21. Global Biologics Regulatory Affairs Outsourcing Market Size by Region (2021-2026) & (US$ Million) Table 22. Global Biologics Regulatory Affairs Outsourcing Market Share by Region (2021-2026) Table 23. Global Biologics Regulatory Affairs Outsourcing Market Size by Region (2027-2032) & (US$ Million) Table 24. Global Biologics Regulatory Affairs Outsourcing Market Share by Region (2027-2032) Table 25. Global Biologics Regulatory Affairs Outsourcing Revenue by Players (US$ Million) & (2021-2026) Table 26. Global Biologics Regulatory Affairs Outsourcing Revenue Market Share by Players (2021-2026) Table 27. Global Biologics Regulatory Affairs Outsourcing Key Players Ranking, 2024 VS 2025 VS 2026 Table 28. Global Biologics Regulatory Affairs Outsourcing Key Players Headquarters & Area Served Table 29. Global Biologics Regulatory Affairs Outsourcing Players, Product Type & Application Table 30. Global Biologics Regulatory Affairs Outsourcing Players Establishment Date Table 31. Global Players Market Concentration Ratio (CR5 and HHI) Table 32. Global Biologics Regulatory Affairs Outsourcing by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 33. Global Biologics Regulatory Affairs Outsourcing Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Biologics Regulatory Affairs Outsourcing Revenue by Type (2021-2026) & (US$ Million) Table 35. Global Biologics Regulatory Affairs Outsourcing Revenue by Type (2027-2032) & (US$ Million) Table 36. Global Biologics Regulatory Affairs Outsourcing Revenue Market Share by Type (2021-2026) Table 37. Global Biologics Regulatory Affairs Outsourcing Revenue Market Share by Type (2027-2032) Table 38. Global Biologics Regulatory Affairs Outsourcing Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Biologics Regulatory Affairs Outsourcing Revenue by Application (2021-2026) & (US$ Million) Table 40. Global Biologics Regulatory Affairs Outsourcing Revenue by Application (2027-2032) & (US$ Million) Table 41. Global Biologics Regulatory Affairs Outsourcing Revenue Market Share by Application (2021-2026) Table 42. Global Biologics Regulatory Affairs Outsourcing Revenue Market Share by Application (2027-2032) Table 43. Lonza AG Company Information Table 44. Lonza AG Business Overview Table 45. Lonza AG Biologics Regulatory Affairs Outsourcing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 46. Lonza AG Biologics Regulatory Affairs Outsourcing Product Portfolio Table 47. Lonza AG Recent Development Table 48. Wuxi AppTec Inc. Company Information Table 49. Wuxi AppTec Inc. Business Overview Table 50. Wuxi AppTec Inc. Biologics Regulatory Affairs Outsourcing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 51. Wuxi AppTec Inc. Biologics Regulatory Affairs Outsourcing Product Portfolio Table 52. Wuxi AppTec Inc. Recent Development Table 53. Thermo Fisher Scientific Inc. Company Information Table 54. Thermo Fisher Scientific Inc. Business Overview Table 55. Thermo Fisher Scientific Inc. Biologics Regulatory Affairs Outsourcing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 56. Thermo Fisher Scientific Inc. Biologics Regulatory Affairs Outsourcing Product Portfolio Table 57. Thermo Fisher Scientific Inc. Recent Development Table 58. Eurofins Scientific SE Company Information Table 59. Eurofins Scientific SE Business Overview Table 60. Eurofins Scientific SE Biologics Regulatory Affairs Outsourcing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 61. Eurofins Scientific SE Biologics Regulatory Affairs Outsourcing Product Portfolio Table 62. Eurofins Scientific SE Recent Development Table 63. Freyr solutions Company Information Table 64. Freyr solutions Business Overview Table 65. Freyr solutions Biologics Regulatory Affairs Outsourcing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 66. Freyr solutions Biologics Regulatory Affairs Outsourcing Product Portfolio Table 67. Freyr solutions Recent Development Table 68. Catalent Inc. Company Information Table 69. Catalent Inc. Business Overview Table 70. Catalent Inc. Biologics Regulatory Affairs Outsourcing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 71. Catalent Inc. Biologics Regulatory Affairs Outsourcing Product Portfolio Table 72. Catalent Inc. Recent Development Table 73. Piramal Group Company Information Table 74. Piramal Group Business Overview Table 75. Piramal Group Biologics Regulatory Affairs Outsourcing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 76. Piramal Group Biologics Regulatory Affairs Outsourcing Product Portfolio Table 77. Piramal Group Recent Development Table 78. AGC Biologics Company Information Table 79. AGC Biologics Business Overview Table 80. AGC Biologics Biologics Regulatory Affairs Outsourcing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 81. AGC Biologics Biologics Regulatory Affairs Outsourcing Product Portfolio Table 82. AGC Biologics Recent Development Table 83. ICON Plc. Company Information Table 84. ICON Plc. Business Overview Table 85. ICON Plc. Biologics Regulatory Affairs Outsourcing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 86. ICON Plc. Biologics Regulatory Affairs Outsourcing Product Portfolio Table 87. ICON Plc. Recent Development Table 88. Charles River Laboratories International, Inc. Company Information Table 89. Charles River Laboratories International, Inc. Business Overview Table 90. Charles River Laboratories International, Inc. Biologics Regulatory Affairs Outsourcing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 91. Charles River Laboratories International, Inc. Biologics Regulatory Affairs Outsourcing Product Portfolio Table 92. Charles River Laboratories International, Inc. Recent Development Table 93. Labcorp Company Information Table 94. Labcorp Business Overview Table 95. Labcorp Biologics Regulatory Affairs Outsourcing Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 96. Labcorp Biologics Regulatory Affairs Outsourcing Product Portfolio Table 97. Labcorp Recent Development Table 98. Parexel International Company Information Table 99. Parexel International Business Overview Table 100. Parexel International Biologics Regulatory Affairs Outsourcing Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 101. Parexel International Biologics Regulatory Affairs Outsourcing Product Portfolio Table 102. Parexel International Recent Development Table 103. Medpace Holdings, Inc. Company Information Table 104. Medpace Holdings, Inc. Business Overview Table 105. Medpace Holdings, Inc. Biologics Regulatory Affairs Outsourcing Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 106. Medpace Holdings, Inc. Biologics Regulatory Affairs Outsourcing Product Portfolio Table 107. Medpace Holdings, Inc. Recent Development Table 108. IQVIA Company Information Table 109. IQVIA Business Overview Table 110. IQVIA Biologics Regulatory Affairs Outsourcing Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 111. IQVIA Biologics Regulatory Affairs Outsourcing Product Portfolio Table 112. IQVIA Recent Development Table 113. Syneos Health Company Information Table 114. Syneos Health Business Overview Table 115. Syneos Health Biologics Regulatory Affairs Outsourcing Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 116. Syneos Health Biologics Regulatory Affairs Outsourcing Product Portfolio Table 117. Syneos Health Recent Development Table 118. SGS SA (SGS) Company Information Table 119. SGS SA (SGS) Business Overview Table 120. SGS SA (SGS) Biologics Regulatory Affairs Outsourcing Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 121. SGS SA (SGS) Biologics Regulatory Affairs Outsourcing Product Portfolio Table 122. SGS SA (SGS) Recent Development Table 123. North America Biologics Regulatory Affairs Outsourcing Revenue by Type (2021-2026) & (US$ Million) Table 124. North America Biologics Regulatory Affairs Outsourcing Revenue by Type (2027-2032) & (US$ Million) Table 125. North America Biologics Regulatory Affairs Outsourcing Revenue by Application (2021-2026) & (US$ Million) Table 126. North America Biologics Regulatory Affairs Outsourcing Revenue by Application (2027-2032) & (US$ Million) Table 127. North America Biologics Regulatory Affairs Outsourcing Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 128. North America Biologics Regulatory Affairs Outsourcing Revenue by Country (2021-2026) & (US$ Million) Table 129. North America Biologics Regulatory Affairs Outsourcing Revenue by Country (US$ Million) & (2027-2032) Table 130. Europe Biologics Regulatory Affairs Outsourcing Revenue by Type (2021-2026) & (US$ Million) Table 131. Europe Biologics Regulatory Affairs Outsourcing Revenue by Type (2027-2032) & (US$ Million) Table 132. Europe Biologics Regulatory Affairs Outsourcing Revenue by Application (2021-2026) & (US$ Million) Table 133. Europe Biologics Regulatory Affairs Outsourcing Revenue by Application (2027-2032) & (US$ Million) Table 134. Europe Biologics Regulatory Affairs Outsourcing Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 135. Europe Biologics Regulatory Affairs Outsourcing Revenue by Country (2021-2026) & (US$ Million) Table 136. Europe Biologics Regulatory Affairs Outsourcing Revenue by Country (US$ Million) & (2027-2032) Table 137. China Biologics Regulatory Affairs Outsourcing Revenue by Type (2021-2026) & (US$ Million) Table 138. China Biologics Regulatory Affairs Outsourcing Revenue by Type (2027-2032) & (US$ Million) Table 139. China Biologics Regulatory Affairs Outsourcing Revenue by Application (2021-2026) & (US$ Million) Table 140. China Biologics Regulatory Affairs Outsourcing Revenue by Application (2027-2032) & (US$ Million) Table 141. Asia Biologics Regulatory Affairs Outsourcing Revenue by Type (2021-2026) & (US$ Million) Table 142. Asia Biologics Regulatory Affairs Outsourcing Revenue by Type (2027-2032) & (US$ Million) Table 143. Asia Biologics Regulatory Affairs Outsourcing Revenue by Application (2021-2026) & (US$ Million) Table 144. Asia Biologics Regulatory Affairs Outsourcing Revenue by Application (2027-2032) & (US$ Million) Table 145. Asia Biologics Regulatory Affairs Outsourcing Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 146. Asia Biologics Regulatory Affairs Outsourcing Revenue by Region (US$ Million) & (2021-2026) Table 147. Asia Biologics Regulatory Affairs Outsourcing Revenue by Region (US$ Million) & (2027-2032) Table 148. SAMEA Biologics Regulatory Affairs Outsourcing Revenue by Type (2021-2026) & (US$ Million) Table 149. SAMEA Biologics Regulatory Affairs Outsourcing Revenue by Type (2027-2032) & (US$ Million) Table 150. SAMEA Biologics Regulatory Affairs Outsourcing Revenue by Application (2021-2026) & (US$ Million) Table 151. SAMEA Biologics Regulatory Affairs Outsourcing Revenue by Application (2027-2032) & (US$ Million) Table 152. SAMEA Biologics Regulatory Affairs Outsourcing Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 153. SAMEA Biologics Regulatory Affairs Outsourcing Revenue by Country (2021-2026) & (US$ Million) Table 154. SAMEA Biologics Regulatory Affairs Outsourcing Revenue by Country (US$ Million) & (2027-2032) Table 155. Research Programs/Design for This Report Table 156. Authors List of This Report Table 157. Secondary Sources Table 158. Primary Sources List of Figures Figure 1. Biologics Regulatory Affairs Outsourcing Image Figure 2. Global Biologics Regulatory Affairs Outsourcing Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Biologics Regulatory Affairs Outsourcing Market Size Share 2021 VS 2025 VS 2032 Figure 4. Regulatory Consulting Image Figure 5. Legal Representation Image Figure 6. Regulatory Writing & Publishing Image Figure 7. Product Registration Image Figure 8. Regulatory Submissions Image Figure 9. Regulatory Operations Image Figure 10. Others Image Figure 11. Global Biologics Regulatory Affairs Outsourcing Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Biologics Regulatory Affairs Outsourcing Market Size Share 2021 VS 2025 VS 2032 Figure 13. Monoclonal Antibodies (mAbs) Image Figure 14. Recombinant Proteins Image Figure 15. Vaccines Image Figure 16. Cell & Gene Therapies Image Figure 17. Biosimilars Image Figure 18. Others Image Figure 19. Global Biologics Regulatory Affairs Outsourcing Market Size (US$ Million) & (2021-2032) Figure 20. Global Biologics Regulatory Affairs Outsourcing Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 21. Global Biologics Regulatory Affairs Outsourcing Market Share by Region: 2021 VS 2025 VS 2032 Figure 22. Global Biologics Regulatory Affairs Outsourcing Players Revenue Share Top 10 and Top 5 in 2025 Figure 23. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 24. Global Biologics Regulatory Affairs Outsourcing Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Biologics Regulatory Affairs Outsourcing Revenue Market Share 2021 VS 2025 VS 2032 Figure 26. Global Biologics Regulatory Affairs Outsourcing Revenue Market Share by Type (2021-2032) Figure 27. Global Biologics Regulatory Affairs Outsourcing Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global Biologics Regulatory Affairs Outsourcing Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 29. Global Biologics Regulatory Affairs Outsourcing Revenue Market Share by Application (2021-2032) Figure 30. North America Biologics Regulatory Affairs Outsourcing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 31. North America Biologics Regulatory Affairs Outsourcing Revenue Share by Type (2021-2032) Figure 32. North America Biologics Regulatory Affairs Outsourcing Revenue Share by Application (2021-2032) Figure 33. North America Biologics Regulatory Affairs Outsourcing Revenue Share by Country (2021-2032) Figure 34. United States Biologics Regulatory Affairs Outsourcing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. Canada Biologics Regulatory Affairs Outsourcing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. Mexico Biologics Regulatory Affairs Outsourcing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Europe Biologics Regulatory Affairs Outsourcing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 38. Europe Biologics Regulatory Affairs Outsourcing Revenue Share by Type (2021-2032) Figure 39. Europe Biologics Regulatory Affairs Outsourcing Revenue Share by Application (2021-2032) Figure 40. Europe Biologics Regulatory Affairs Outsourcing Revenue Share by Country (2021-2032) Figure 41. Germany Biologics Regulatory Affairs Outsourcing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. France Biologics Regulatory Affairs Outsourcing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. U.K. Biologics Regulatory Affairs Outsourcing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 44. Italy Biologics Regulatory Affairs Outsourcing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 45. Spain Biologics Regulatory Affairs Outsourcing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 46. Russia Biologics Regulatory Affairs Outsourcing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 47. Netherlands Biologics Regulatory Affairs Outsourcing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 48. Nordic Countries Biologics Regulatory Affairs Outsourcing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 49. China Biologics Regulatory Affairs Outsourcing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 50. China Biologics Regulatory Affairs Outsourcing Revenue Share by Type (2021-2032) Figure 51. China Biologics Regulatory Affairs Outsourcing Revenue Share by Application (2021-2032) Figure 52. Asia Biologics Regulatory Affairs Outsourcing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 53. Asia Biologics Regulatory Affairs Outsourcing Revenue Share by Type (2021-2032) Figure 54. Asia Biologics Regulatory Affairs Outsourcing Revenue Share by Application (2021-2032) Figure 55. Asia Biologics Regulatory Affairs Outsourcing Revenue Share by Region (2021-2032) Figure 56. Japan Biologics Regulatory Affairs Outsourcing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 57. South Korea Biologics Regulatory Affairs Outsourcing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 58. India Biologics Regulatory Affairs Outsourcing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 59. Australia Biologics Regulatory Affairs Outsourcing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Taiwan Biologics Regulatory Affairs Outsourcing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Southeast Asia Biologics Regulatory Affairs Outsourcing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. SAMEA Biologics Regulatory Affairs Outsourcing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 63. SAMEA Biologics Regulatory Affairs Outsourcing Revenue Share by Type (2021-2032) Figure 64. SAMEA Biologics Regulatory Affairs Outsourcing Revenue Share by Application (2021-2032) Figure 65. SAMEA Biologics Regulatory Affairs Outsourcing Revenue Share by Country (2021-2032) Figure 66. Brazil Biologics Regulatory Affairs Outsourcing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Argentina Biologics Regulatory Affairs Outsourcing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Chile Biologics Regulatory Affairs Outsourcing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Colombia Biologics Regulatory Affairs Outsourcing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Peru Biologics Regulatory Affairs Outsourcing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Saudi Arabia Biologics Regulatory Affairs Outsourcing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 72. Israel Biologics Regulatory Affairs Outsourcing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 73. UAE Biologics Regulatory Affairs Outsourcing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 74. Turkey Biologics Regulatory Affairs Outsourcing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 75. Iran Biologics Regulatory Affairs Outsourcing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 76. Egypt Biologics Regulatory Affairs Outsourcing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 77. Years Considered Figure 78. Research Process Figure 79. Key Executives Interviewed

Scope & coverage.

Types
  • Regulatory Consulting
  • Legal Representation
  • Regulatory Writing & Publishing
  • Product Registration
  • Regulatory Submissions
  • Regulatory Operations
  • Others
Applications
  • Monoclonal Antibodies (mAbs)
  • Recombinant Proteins
  • Vaccines
  • Cell & Gene Therapies
  • Biosimilars
  • Others
Companies covered
  • Lonza AG
  • Wuxi AppTec Inc.
  • Thermo Fisher Scientific Inc.
  • Eurofins Scientific SE
  • Freyr solutions
  • Catalent Inc.
  • Piramal Group
  • AGC Biologics
  • ICON Plc.
  • Charles River Laboratories International, Inc.
  • Labcorp
  • Parexel International
  • Medpace Holdings, Inc.
  • IQVIA
  • Syneos Health
  • SGS SA (SGS)

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Biologics Regulatory Affairs Outsourcing Market by Type
  3. 1.2.1 Global Biologics Regulatory Affairs Outsourcing Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Regulatory Consulting
  5. 1.2.3 Legal Representation
  6. 1.2.4 Regulatory Writing & Publishing
  7. 1.2.5 Product Registration
  8. 1.2.6 Regulatory Submissions
  9. 1.2.7 Regulatory Operations
  10. 1.2.8 Others
  11. 1.3 Biologics Regulatory Affairs Outsourcing Market by Application
  12. 1.3.1 Global Biologics Regulatory Affairs Outsourcing Market Size by Application, 2021 VS 2025 VS 2032
  13. 1.3.2 Monoclonal Antibodies (mAbs)
  14. 1.3.3 Recombinant Proteins
  15. 1.3.4 Vaccines
  16. 1.3.5 Cell & Gene Therapies
  17. 1.3.6 Biosimilars
  18. 1.3.7 Others
  19. 1.4 Assumptions and Limitations
  20. 1.5 Study Goals and Objectives
2 Biologics Regulatory Affairs Outsourcing Market Dynamics
  1. 2.1 Biologics Regulatory Affairs Outsourcing Industry Trends
  2. 2.2 Biologics Regulatory Affairs Outsourcing Industry Drivers
  3. 2.3 Biologics Regulatory Affairs Outsourcing Industry Opportunities and Challenges
  4. 2.4 Biologics Regulatory Affairs Outsourcing Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Biologics Regulatory Affairs Outsourcing Market Perspective (2021-2032)
  2. 3.2 Global Biologics Regulatory Affairs Outsourcing Growth Trends by Region
  3. 3.2.1 Global Biologics Regulatory Affairs Outsourcing Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Biologics Regulatory Affairs Outsourcing Market Size by Region (2021-2026)
  5. 3.2.3 Global Biologics Regulatory Affairs Outsourcing Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Biologics Regulatory Affairs Outsourcing Revenue by Players
  2. 4.1.1 Global Biologics Regulatory Affairs Outsourcing Revenue by Players (2021-2026)
  3. 4.1.2 Global Biologics Regulatory Affairs Outsourcing Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Biologics Regulatory Affairs Outsourcing Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Biologics Regulatory Affairs Outsourcing Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Biologics Regulatory Affairs Outsourcing Key Players Headquarters & Area Served
  7. 4.4 Global Biologics Regulatory Affairs Outsourcing Players, Product Type & Application
  8. 4.5 Global Biologics Regulatory Affairs Outsourcing Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Biologics Regulatory Affairs Outsourcing Market CR5 and HHI
  11. 4.6.3 2025 Biologics Regulatory Affairs Outsourcing Tier 1, Tier 2, and Tier 3
5 Biologics Regulatory Affairs Outsourcing Market Size by Type
  1. 5.1 Global Biologics Regulatory Affairs Outsourcing Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Biologics Regulatory Affairs Outsourcing Revenue by Type (2021-2032)
  3. 5.3 Global Biologics Regulatory Affairs Outsourcing Revenue Market Share by Type (2021-2032)
6 Biologics Regulatory Affairs Outsourcing Market Size by Application
  1. 6.1 Global Biologics Regulatory Affairs Outsourcing Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Biologics Regulatory Affairs Outsourcing Revenue by Application (2021-2032)
  3. 6.3 Global Biologics Regulatory Affairs Outsourcing Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Lonza AG
  2. 7.1.1 Lonza AG Company Information
  3. 7.1.2 Lonza AG Business Overview
  4. 7.1.3 Lonza AG Biologics Regulatory Affairs Outsourcing Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Lonza AG Biologics Regulatory Affairs Outsourcing Product Portfolio
  6. 7.1.5 Lonza AG Recent Developments
  7. 7.2 Wuxi AppTec Inc.
  8. 7.2.1 Wuxi AppTec Inc. Company Information
  9. 7.2.2 Wuxi AppTec Inc. Business Overview
  10. 7.2.3 Wuxi AppTec Inc. Biologics Regulatory Affairs Outsourcing Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Wuxi AppTec Inc. Biologics Regulatory Affairs Outsourcing Product Portfolio
  12. 7.2.5 Wuxi AppTec Inc. Recent Developments
  13. 7.3 Thermo Fisher Scientific Inc.
  14. 7.3.1 Thermo Fisher Scientific Inc. Company Information
  15. 7.3.2 Thermo Fisher Scientific Inc. Business Overview
  16. 7.3.3 Thermo Fisher Scientific Inc. Biologics Regulatory Affairs Outsourcing Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Thermo Fisher Scientific Inc. Biologics Regulatory Affairs Outsourcing Product Portfolio
  18. 7.3.5 Thermo Fisher Scientific Inc. Recent Developments
  19. 7.4 Eurofins Scientific SE
  20. 7.4.1 Eurofins Scientific SE Company Information
  21. 7.4.2 Eurofins Scientific SE Business Overview
  22. 7.4.3 Eurofins Scientific SE Biologics Regulatory Affairs Outsourcing Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Eurofins Scientific SE Biologics Regulatory Affairs Outsourcing Product Portfolio
  24. 7.4.5 Eurofins Scientific SE Recent Developments
  25. 7.5 Freyr solutions
  26. 7.5.1 Freyr solutions Company Information
  27. 7.5.2 Freyr solutions Business Overview
  28. 7.5.3 Freyr solutions Biologics Regulatory Affairs Outsourcing Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Freyr solutions Biologics Regulatory Affairs Outsourcing Product Portfolio
  30. 7.5.5 Freyr solutions Recent Developments
  31. 7.6 Catalent Inc.
  32. 7.6.1 Catalent Inc. Company Information
  33. 7.6.2 Catalent Inc. Business Overview
  34. 7.6.3 Catalent Inc. Biologics Regulatory Affairs Outsourcing Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Catalent Inc. Biologics Regulatory Affairs Outsourcing Product Portfolio
  36. 7.6.5 Catalent Inc. Recent Developments
  37. 7.7 Piramal Group
  38. 7.7.1 Piramal Group Company Information
  39. 7.7.2 Piramal Group Business Overview
  40. 7.7.3 Piramal Group Biologics Regulatory Affairs Outsourcing Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Piramal Group Biologics Regulatory Affairs Outsourcing Product Portfolio
  42. 7.7.5 Piramal Group Recent Developments
  43. 7.8 AGC Biologics
  44. 7.8.1 AGC Biologics Company Information
  45. 7.8.2 AGC Biologics Business Overview
  46. 7.8.3 AGC Biologics Biologics Regulatory Affairs Outsourcing Revenue and Gross Margin (2021-2026)
  47. 7.8.4 AGC Biologics Biologics Regulatory Affairs Outsourcing Product Portfolio
  48. 7.8.5 AGC Biologics Recent Developments
  49. 7.9 ICON Plc.
  50. 7.9.1 ICON Plc. Company Information
  51. 7.9.2 ICON Plc. Business Overview
  52. 7.9.3 ICON Plc. Biologics Regulatory Affairs Outsourcing Revenue and Gross Margin (2021-2026)
  53. 7.9.4 ICON Plc. Biologics Regulatory Affairs Outsourcing Product Portfolio
  54. 7.9.5 ICON Plc. Recent Developments
  55. 7.10 Charles River Laboratories International, Inc.
  56. 7.10.1 Charles River Laboratories International, Inc. Company Information
  57. 7.10.2 Charles River Laboratories International, Inc. Business Overview
  58. 7.10.3 Charles River Laboratories International, Inc. Biologics Regulatory Affairs Outsourcing Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Charles River Laboratories International, Inc. Biologics Regulatory Affairs Outsourcing Product Portfolio
  60. 7.10.5 Charles River Laboratories International, Inc. Recent Developments
  61. 7.11 Labcorp
  62. 7.11.1 Labcorp Company Information
  63. 7.11.2 Labcorp Business Overview
  64. 7.11.3 Labcorp Biologics Regulatory Affairs Outsourcing Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Labcorp Biologics Regulatory Affairs Outsourcing Product Portfolio
  66. 7.11.5 Labcorp Recent Developments
  67. 7.12 Parexel International
  68. 7.12.1 Parexel International Company Information
  69. 7.12.2 Parexel International Business Overview
  70. 7.12.3 Parexel International Biologics Regulatory Affairs Outsourcing Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Parexel International Biologics Regulatory Affairs Outsourcing Product Portfolio
  72. 7.12.5 Parexel International Recent Developments
  73. 7.13 Medpace Holdings, Inc.
  74. 7.13.1 Medpace Holdings, Inc. Company Information
  75. 7.13.2 Medpace Holdings, Inc. Business Overview
  76. 7.13.3 Medpace Holdings, Inc. Biologics Regulatory Affairs Outsourcing Revenue and Gross Margin (2021-2026)
  77. 7.13.4 Medpace Holdings, Inc. Biologics Regulatory Affairs Outsourcing Product Portfolio
  78. 7.13.5 Medpace Holdings, Inc. Recent Developments
  79. 7.14 IQVIA
  80. 7.14.1 IQVIA Company Information
  81. 7.14.2 IQVIA Business Overview
  82. 7.14.3 IQVIA Biologics Regulatory Affairs Outsourcing Revenue and Gross Margin (2021-2026)
  83. 7.14.4 IQVIA Biologics Regulatory Affairs Outsourcing Product Portfolio
  84. 7.14.5 IQVIA Recent Developments
  85. 7.15 Syneos Health
  86. 7.15.1 Syneos Health Company Information
  87. 7.15.2 Syneos Health Business Overview
  88. 7.15.3 Syneos Health Biologics Regulatory Affairs Outsourcing Revenue and Gross Margin (2021-2026)
  89. 7.15.4 Syneos Health Biologics Regulatory Affairs Outsourcing Product Portfolio
  90. 7.15.5 Syneos Health Recent Developments
  91. 7.16 SGS SA (SGS)
  92. 7.16.1 SGS SA (SGS) Company Information
  93. 7.16.2 SGS SA (SGS) Business Overview
  94. 7.16.3 SGS SA (SGS) Biologics Regulatory Affairs Outsourcing Revenue and Gross Margin (2021-2026)
  95. 7.16.4 SGS SA (SGS) Biologics Regulatory Affairs Outsourcing Product Portfolio
  96. 7.16.5 SGS SA (SGS) Recent Developments
8 North America
  1. 8.1 North America Biologics Regulatory Affairs Outsourcing Revenue (2021-2032)
  2. 8.2 North America Biologics Regulatory Affairs Outsourcing Revenue by Type (2021-2032)
  3. 8.2.1 North America Biologics Regulatory Affairs Outsourcing Revenue by Type (2021-2026)
  4. 8.2.2 North America Biologics Regulatory Affairs Outsourcing Revenue by Type (2027-2032)
  5. 8.3 North America Biologics Regulatory Affairs Outsourcing Revenue Share by Type (2021-2032)
  6. 8.4 North America Biologics Regulatory Affairs Outsourcing Revenue by Application (2021-2032)
  7. 8.4.1 North America Biologics Regulatory Affairs Outsourcing Revenue by Application (2021-2026)
  8. 8.4.2 North America Biologics Regulatory Affairs Outsourcing Revenue by Application (2027-2032)
  9. 8.5 North America Biologics Regulatory Affairs Outsourcing Revenue Share by Application (2021-2032)
  10. 8.6 North America Biologics Regulatory Affairs Outsourcing Revenue by Country
  11. 8.6.1 North America Biologics Regulatory Affairs Outsourcing Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Biologics Regulatory Affairs Outsourcing Revenue by Country (2021-2026)
  13. 8.6.3 North America Biologics Regulatory Affairs Outsourcing Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Biologics Regulatory Affairs Outsourcing Revenue (2021-2032)
  2. 9.2 Europe Biologics Regulatory Affairs Outsourcing Revenue by Type (2021-2032)
  3. 9.2.1 Europe Biologics Regulatory Affairs Outsourcing Revenue by Type (2021-2026)
  4. 9.2.2 Europe Biologics Regulatory Affairs Outsourcing Revenue by Type (2027-2032)
  5. 9.3 Europe Biologics Regulatory Affairs Outsourcing Revenue Share by Type (2021-2032)
  6. 9.4 Europe Biologics Regulatory Affairs Outsourcing Revenue by Application (2021-2032)
  7. 9.4.1 Europe Biologics Regulatory Affairs Outsourcing Revenue by Application (2021-2026)
  8. 9.4.2 Europe Biologics Regulatory Affairs Outsourcing Revenue by Application (2027-2032)
  9. 9.5 Europe Biologics Regulatory Affairs Outsourcing Revenue Share by Application (2021-2032)
  10. 9.6 Europe Biologics Regulatory Affairs Outsourcing Revenue by Country
  11. 9.6.1 Europe Biologics Regulatory Affairs Outsourcing Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Biologics Regulatory Affairs Outsourcing Revenue by Country (2021-2026)
  13. 9.6.3 Europe Biologics Regulatory Affairs Outsourcing Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Biologics Regulatory Affairs Outsourcing Revenue (2021-2032)
  2. 10.2 China Biologics Regulatory Affairs Outsourcing Revenue by Type (2021-2032)
  3. 10.2.1 China Biologics Regulatory Affairs Outsourcing Revenue by Type (2021-2026)
  4. 10.2.2 China Biologics Regulatory Affairs Outsourcing Revenue by Type (2027-2032)
  5. 10.3 China Biologics Regulatory Affairs Outsourcing Revenue Share by Type (2021-2032)
  6. 10.4 China Biologics Regulatory Affairs Outsourcing Revenue by Application (2021-2032)
  7. 10.4.1 China Biologics Regulatory Affairs Outsourcing Revenue by Application (2021-2026)
  8. 10.4.2 China Biologics Regulatory Affairs Outsourcing Revenue by Application (2027-2032)
  9. 10.5 China Biologics Regulatory Affairs Outsourcing Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Biologics Regulatory Affairs Outsourcing Revenue (2021-2032)
  2. 11.2 Asia Biologics Regulatory Affairs Outsourcing Revenue by Type (2021-2032)
  3. 11.2.1 Asia Biologics Regulatory Affairs Outsourcing Revenue by Type (2021-2026)
  4. 11.2.2 Asia Biologics Regulatory Affairs Outsourcing Revenue by Type (2027-2032)
  5. 11.3 Asia Biologics Regulatory Affairs Outsourcing Revenue Share by Type (2021-2032)
  6. 11.4 Asia Biologics Regulatory Affairs Outsourcing Revenue by Application (2021-2032)
  7. 11.4.1 Asia Biologics Regulatory Affairs Outsourcing Revenue by Application (2021-2026)
  8. 11.4.2 Asia Biologics Regulatory Affairs Outsourcing Revenue by Application (2027-2032)
  9. 11.5 Asia Biologics Regulatory Affairs Outsourcing Revenue Share by Application (2021-2032)
  10. 11.6 Asia Biologics Regulatory Affairs Outsourcing Revenue by Country
  11. 11.6.1 Asia Biologics Regulatory Affairs Outsourcing Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Biologics Regulatory Affairs Outsourcing Revenue by Country (2021-2026)
  13. 11.6.3 Asia Biologics Regulatory Affairs Outsourcing Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Biologics Regulatory Affairs Outsourcing Revenue (2021-2032)
  2. 12.2 SAMEA Biologics Regulatory Affairs Outsourcing Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Biologics Regulatory Affairs Outsourcing Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Biologics Regulatory Affairs Outsourcing Revenue by Type (2027-2032)
  5. 12.3 SAMEA Biologics Regulatory Affairs Outsourcing Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Biologics Regulatory Affairs Outsourcing Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Biologics Regulatory Affairs Outsourcing Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Biologics Regulatory Affairs Outsourcing Revenue by Application (2027-2032)
  9. 12.5 SAMEA Biologics Regulatory Affairs Outsourcing Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Biologics Regulatory Affairs Outsourcing Revenue by Country
  11. 12.6.1 SAMEA Biologics Regulatory Affairs Outsourcing Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Biologics Regulatory Affairs Outsourcing Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Biologics Regulatory Affairs Outsourcing Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst